Evidence map›Paper›PMID 37072874›Full record

ArticleAntimicrobial resistance and infection control2023

Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018.

Wallis Rudnick, John Conly, Daniel J G Thirion, Kelly Choi, Linda Pelude, Joelle Cayen, John Bautista, Lizanne Beique, Jeannette L Comeau, Bruce Dalton and 23 more

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Wallis RudnickPublic Health Agency of Canada, 130 Colonnade Rd, Ottawa, ON, K2E 7L9, Canada.
John ConlyUniversity of Calgary, 3330 Hospital Dr NW, Calgary, AB, T2N 4N1, Canada.
Daniel J G ThirionUniversité de Montréal, 2900 Boulevard Edouard-Montpetit, Montréal, QC, H3T 1J4, Canada.
Kelly ChoiPublic Health Agency of Canada, 130 Colonnade Rd, Ottawa, ON, K2E 7L9, Canada.
Linda PeludePublic Health Agency of Canada, 130 Colonnade Rd, Ottawa, ON, K2E 7L9, Canada.
Joelle CayenPublic Health Agency of Canada, 130 Colonnade Rd, Ottawa, ON, K2E 7L9, Canada.
John BautistaCentral Newfoundland Regional Health Centre, 50 Union, Grand Falls-Windsor, NL, A2A 2E1, Canada.
Lizanne BeiquePublic Health Agency of Canada, 130 Colonnade Rd, Ottawa, ON, K2E 7L9, Canada.
Jeannette L ComeauDalhousie University, 6299 South St, Halifax, NS, B3H 4R2, Canada.
Bruce DaltonAlberta Health Services, 1620 29 St NW, Calgary, AB, T2N 4L7, Canada.
Johan DelportLondon Health Sciences Centre, 800 Commissioners Rd E, London, ON, N6A 5W9, Canada.
Rita DhamiLondon Health Sciences Centre, 800 Commissioners Rd E, London, ON, N6A 5W9, Canada.
Joanne EmbreeUniversity of Manitoba, Winnipeg, MB, R3T 2N2, Canada.
Yannick ÉmondHôpital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montréal, QC, H1T 2M4, Canada.
Gerald EvansKingston Health Sciences Centre, 76 Stuart St, Kingston, ON, K7L 2V7, Canada.
Charles FrenetteMcGill University Health Centre, 1001 Boulevard Décarie, Montréal, QC, H4A 3J1, Canada.
Susan FrytersAlberta Health Services, 10240 Kingsway Avenue, Edmonton, AB, T5H 3V9, Canada.
Jennifer HappeInfection Prevention and Control Canada, Red Deer, AB, T4N 6R2, Canada.
Kevin KatzNorth York General Hospital, 4001 Leslie St, North York, ON, M2K 1E1, Canada.
Pamela KibseyRoyal Jubilee Hospital, 1952 Bay St, Victoria, BC, V8R 1J8, Canada.
Joanne M LangleyIWK Health Centre, 5980 University Ave, Halifax, NS, B3K 6R8, Canada.
Bonita E LeeStollery Children's Hospital, Edmonton, AB, T6G 2B7, Canada.
Marie-Astrid LefebvreMcGill University Health Centre, 1001 Boulevard Décarie, Montréal, QC, H4A 3J1, Canada.
Jerome A LeisDepartment of Medicine, University of Toronto, 1 King's College Cir, Toronto, ON, M5S 1A8, Canada.
Allison McGeerSinai Health System, 600 University Ave, Toronto, ON, M5G 1X5, Canada.
Susan McKennaKingston Health Sciences Centre, 76 Stuart St, Kingston, ON, K7L 2V7, Canada.
Heather L NevilleNova Scotia Health, 1276 South Park St, Halifax, NS, B3H 2Y9, Canada.
Kathryn SlayterIWK Health Centre, 5980 University Ave, Halifax, NS, B3K 6R8, Canada.
Kathryn N SuhThe Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada.
Alena Tse-ChangStollery Children's Hospital, Edmonton, AB, T6G 2B7, Canada.
Karl WeissSMBD-Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montréal, QC, H3T 1E2, Canada.
Michelle ScienceSickKids, 555 University Ave, Toronto, ON, M5G 1X8, Canada. michelle.science@sickkids.ca.
Canadian Nosocomial Infection Surveillance Program

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistance threatens the ability to successfully prevent and treat infections. While hospital benchmarks regarding antimicrobial use (AMU) have been well documented among adult populations, there is less information from among paediatric inpatients. This study presents benchmark rates of antimicrobial use (AMU) for paediatric inpatients in nine Canadian acute-care hospitals.

methodsAcute-care hospitals participating in the Canadian Nosocomial Infection Surveillance Program submitted annual AMU data from paediatric inpatients from 2017 and 2018. All systemic antimicrobials were included. Data were available for neonatal intensive care units (NICUs), pediatric ICUs (PICUs), and non-ICU wards. Data were analyzed using days of therapy (DOT) per 1000 patient days (DOT/1000pd).

resultsNine hospitals provided paediatric AMU data. Data from seven NICU and PICU wards were included. Overall AMU was 481 (95% CI 409-554) DOT/1000pd. There was high variability in AMU between hospitals. AMU was higher on PICU wards (784 DOT/1000pd) than on non-ICU (494 DOT/1000pd) or NICU wards (333 DOT/1000pd). On non-ICU wards, the antimicrobials with the highest use were cefazolin (66 DOT/1000pd), ceftriaxone (59 DOT/1000pd) and piperacillin-tazobactam (48 DOT/1000pd). On PICU wards, the antimicrobials with the highest use were ceftriaxone (115 DOT/1000pd), piperacillin-tazobactam (115 DOT/1000pd), and cefazolin (111 DOT/1000pd). On NICU wards, the antimicrobials with the highest use were ampicillin (102 DOT/1000pd), gentamicin/tobramycin (78 DOT/1000pd), and cefotaxime (38 DOT/1000pd).

conclusionsThis study represents the largest collection of antimicrobial use data among hospitalized paediatric inpatients in Canada to date. In 2017/2018, overall AMU was 481 DOT/1000pd. National surveillance of AMU among paediatric inpatients is necessary for establishing benchmarks and informing antimicrobial stewardship efforts.

Indexed as

Anti-Infective AgentsCross InfectionAdultCanadaCefazolinCeftriaxoneChildHospitalsHumansInfant, NewbornInpatientsPiperacillinTazobactamAnti-Infective AgentsCefazolinCeftriaxonePiperacillinTazobactamAntimicrobial useHospitalPaediatricSurveillance

Identifiers

PMID37072874
PMCPMC10111695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.